The World Health Organization and the European Medicines Agency on the Oxford – AstraZeneca Covid-19 vaccine, whose use was suspended in many countries around the world, especially in Europe, last week due to blood clot problems, said the benefit of the vaccine was greater than the harm. In addition, many countries continue to vaccinate, while some countries continue their research on the vaccine.

AT LEAST THE COUNTRY HAD SUSPENDED

The European Medicines Agency (EMA) and the World Health Organization (WHO) on the Oxford / AstraZeneca Covid-19 vaccine, whose use has been suspended by many countries around the world due to blood clot problems, said its benefits outweigh their risks.

At least 17 countries in Europe have suspended or delayed the use of the vaccine following reports of people being admitted to hospitals for clotting and bleeding problems after being vaccinated.

WHO’S’ CONTINUING VACCINATION ‘ PROPOSAL

AstraZeneca and the European Medicines Agency said concerns about clotting problems had not been raised in human trials, while the World Health Organization (who) said it recommended continuing vaccination, with global corona virus casualties reaching 2.8 million.

In addition, many countries have announced that they will continue to use the Oxford – AstraZeneca covid-19 vaccine, while many countries have said they are continuing to suspend it. Here are the countries that have announced they will continue to use the corona virus vaccine, developed by Oxford / AstraZeneca, and continue the decision to suspend it:

FRANCE

France’s drug regulator said the Oxford / AstraZeneca Covid-19 vaccine was allowed to be reused in the country as of March 19, while the vaccine would only be administered to people aged 55 and older.

BULGARIA

The head of Bulgaria’s pharmaceutical agency said the investigation into the death of a Bulgarian person hours after receiving the AstraZeneca vaccine had no direct connection to the vaccine, explaining that as of March 19th, the Oxford / AstraZeneca Covid-19 vaccine continues to be used in the country.

SOUTHERN CYPRUS

Oxford / AstraZeneca announced that it had suspended the use of the Covid-19 vaccine nationwide on March 15, and that the vaccine had begun to be used again as of March 19.

GERMANY

Germany, like its neighbour France, has reintroduced the Oxford / AstraZeneca covid-19 vaccine as of March 19.

IRELAND

The Irish National immunity Advisory Committee announced on March 14 that it had suspended the Oxford / AstraZeneca Covid-19 vaccine. As of March 19, the committee said it planned to continue making the vaccine available in the coming days for everyone aged 18 and older.

ITALY

Announcing the recommendation to Mario Draghi’s government, Italy’s health panel President Franco Locatelli said the Oxford / AstraZeneca Covid-19 vaccine continued to be used as of March 19. Locatelli said that people who do not want the Oxford / AstraZeneca Covid-19 vaccine will be offered an alternative vaccine in the future.

NETHERLANDS

The country will continue to use the Oxford / AstraZeneca Covid-19 vaccine next week as the European Medicines Agency (EMA) says the vaccine is still safe after a review, the Dutch health minister said on Thursday.